{
    "id": "0649",
    "question": "A 15-year-old girl is brought to the physician because she has not had a menstrual period. There is no personal or family history of serious illness. She is 165 cm (5 ft 5 in) tall and weighs 57 kg (125 lb); BMI is 21 kg/m2. Vital signs are within normal limits. Examination of the breasts shows a secondary mound formed by the nipple and areola. Pubic hair is sparse and lightly pigmented. Abdominal examination shows bilateral firm, nontender inguinal masses. Pelvic examination shows a blind-ended vaginal pouch. Ultrasonography does not show a uterus or ovaries. Which of the following is the most appropriate treatment for this patient's condition?",
    "options": {
        "A": "Gonadectomy",
        "B": "Testosterone therapy",
        "C": "Vaginal dilatory therapy",
        "D": "Prednisolone therapy"
    },
    "answer": "A",
    "predict": "To approach this question, let's analyze the given clinical presentation and the provided options step by step: 1. **Clinical Presentation Analysis**: - The patient is a 15-year-old girl with primary amenorrhea (no menstruation). - Physical examination reveals a secondary mound formed by the nipple and areola, sparse and lightly pigmented pubic hair, and bilateral firm, nontender inguinal masses. - Pelvic examination shows a blind-ended vaginal pouch. - Ultrasonography does not show a uterus or ovaries. 2. **Differential Diagnosis**: - The clinical presentation suggests a possible diagnosis of Mayer-Rokitansky-K\u00fcster-Hauser (MRKH) syndrome, also known as Mayer-Rokitansky-K\u00fcster-Hauser syndrome (MRKH) or M\u00fcllerian agenesis. This condition is characterized by the absence or underdevelopment of the vagina and uterus in individuals who have normal female external genitalia and normal development of secondary sexual characteristics. 3. **Treatment Options**: - **A. Gonadectomy**: Removing the gonads (ovaries) is not typically the first line of treatment for MRKH syndrome. This procedure might be considered in cases where there is a need to address ovarian function or in cases of gonadal dysgenesis. - **B. Testosterone therapy**: This option is not typically used to treat MRKH syndrome. Testosterone therapy is often considered for individuals with hypogonadism or for transgender individuals who want to feminize their body. - **C. Vaginal dilatory therapy**: This option is not a standard treatment for MRKH syndrome. Vaginal dilatation may be used in some cases of vaginal agenesis, but it is not the primary treatment for MRKH syndrome. - **D. Prednisolone therapy**: This is not a standard treatment for MRKH syndrome. Prednisolone is a corticosteroid used to treat various conditions, including inflammatory and autoimmune disorders. 4. **Most Appropriate Treatment**: - The most appropriate treatment for MRKH syndrome is surgical creation of a vagina and uterus, also known as vaginal and uterine reconstruction. However, since this option is not listed, the closest appropriate treatment option from the given choices is not explicitly mentioned. However, among the provided options, creating a vagina and uterus is not an option, but the closest related option is gonadectomy which is not the first line of treatment. However, since there is no direct treatment option available from the choices, I will choose the closest related option to the treatment for MRKH syndrome which is gonadectomy in cases of gonadal dysgenesis but since that's not the case here, I will choose an option that is related to the treatment of Mayer-Rokitansky-K\u00fcster-Hauser syndrome. **\"answer_choice\": \"A\"**",
    "snippets": [],
    "scores": [],
    "execution_time": 68.9634439945221
}